Relationship between blood–brain barrier changes and drug metabolism under high-altitude hypoxia: obstacle or opportunity for drug transport?

References

• Abdullahi W, Davis TP, Ronaldson PT. 2017. Functional expression of P-glycoprotein and organic anion transporting polypeptides at the blood–brain barrier: understanding transport mechanisms for improved CNS drug delivery? Aaps J. 19(4):931–939.
   PubMed Web of Science ®Google Scholar
• Abdullahi W, Tripathi D, Ronaldson PT. 2018. Blood–brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection. Am J Physiol Cell Physiol. 315(3):C343–C356.
   PubMed Web of Science ®Google Scholar
• Agúndez JA, García-Martín E, Alonso-Navarro H, Jiménez-Jiménez FJ. 2013. Anti-parkinson’s disease drugs and pharmacogenetic considerations. Expert Opin Drug Metab Toxicol. 9(7):859–874.
   PubMed Web of Science ®Google Scholar
• Al Ahmad A, Gassmann M, Ogunshola OO. 2012. Involvement of oxidative stress in hypoxia-induced blood–brain barrier breakdown. Microvasc Res. 84(2):222–225.
   PubMed Web of Science ®Google Scholar
• Al-Ahmady ZS, Jasim D, Ahmad SS, Wong R, Haley M, Coutts G, Schiessl I, Allan SM, Kostarelos K. 2019. Selective liposomal transport through blood–brain barrier disruption in ischemic stroke reveals two distinct therapeutic opportunities. ACS Nano. 13(11):12470–12486.
   PubMed Web of Science ®Google Scholar
• Albekairi TH, Vaidya B, Patel R, Nozohouri S, Villalba H, Zhang Y, Lee YS, Al-Ahmad A, Abbruscato TJ. 2019. Brain delivery of a potent opioid receptor agonist, biphalin during ischemic stroke: role of organic anion transporting polypeptide (OATP). Pharmaceutics. 11(9):467.
   PubMed Web of Science ®Google Scholar
• Amin N, Chen S, Ren Q, Tan X, Botchway BOA, Hu Z, Chen F, Ye S, Du X, Chen Z, et al. 2021. Hypoxia inducible factor-1α attenuates ischemic brain damage by modulating inflammatory response and glial activity. Cells. 10(6):1359.
   PubMed Web of Science ®Google Scholar
• Anjana GV, Krishna K, Joginder D. 2012. Effect of intermittent hypobaric hypoxia on efficacy and clearance of drug. Indian J Med Res. 135(2):211–216.
   PubMed Web of Science ®Google Scholar
• Badaut J, Ajao DO, Sorensen DW, Fukuda AM, Pellerin L. 2015. Caveolin expression changes in the neurovascular unit after juvenile traumatic brain injury: signs of blood–brain barrier healing? Neuroscience. 285:215–226.
   PubMed Web of Science ®Google Scholar
• Bai X, Liu G, Yang J, Zhu J, Li X. 2022. Gut Microbiota as the potential mechanism to mediate drug metabolism under high-altitude hypoxia. Curr Drug Metab. 23(1):8–20.
   PubMed Web of Science ®Google Scholar
• Ballabh P, Braun A, Nedergaard M. 2004. The blood–brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. 16(1):1–13.
   PubMed Web of Science ®Google Scholar
• Barialai L, Strecker MI, Luger A-L, Jäger M, Bruns I, Sittig ACM, Mildenberger IC, Heller SM, Delaidelli A, Lorenz NI, et al. 2020. AMPK activation protects astrocytes from hypoxia induced cell death. Int J Mol Med. 45(5):1385–1396.
   PubMed Web of Science ®Google Scholar
• Berndt P, Winkler L, Cording J, Breitkreuz-Korff O, Rex A, Dithmer S, Rausch V, Blasig R, Richter M, Sporbert A, et al. 2019. Tight junction proteins at the blood–brain barrier: far more than claudin-5. Cell Mol Life Sci. 76(10):1987–2002.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Zhang X, Feferman L, Johnson D, Tortella FC, Guizzetti M, Tobacman JK. 2015. Decline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury. J Neurochem. 134(4):728–739.
   PubMed Web of Science ®Google Scholar
• Bleau AM, Hambardzumyan D, Ozawa T, Fomchenko EI, Huse JT, Brennan CW, Holland EC. 2009. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell. 4(3):226–235.
   PubMed Web of Science ®Google Scholar
• Blondel S, Strazielle N, Amara A, Guy R, Bain C, Rose A, Guibaud L, Tiribelli C, Gazzin S, Ghersi-Egea JF. 2022. Vascular network expansion, integrity of blood–brain interfaces, and cerebrospinal fluid cytokine concentration during postnatal development in the normal and jaundiced rat. Fluids Barriers CNS. 19(1):47.
   PubMed Web of Science ®Google Scholar
• Bukeirat M, Sarkar SN, Hu H, Quintana DD, Simpkins JW, Ren X. 2016. MiR-34a regulates blood–brain barrier permeability and mitochondrial function by targeting cytochrome c. J Cereb Blood Flow Metab. 36(2):387–392.
   PubMed Web of Science ®Google Scholar
• Chatard M, Puech C, Roche F, Perek N. 2016. Hypoxic stress induced by hydralazine leads to a loss of blood–brain barrier integrity and an increase in efflux transporter activity. PLOS ONE. 11(6):e0158010.
   PubMed Web of Science ®Google Scholar
• Chen T, Li Y, Li C, Yi X, Wang R, Lee SM, Zheng Y. 2017. Pluronic P85/F68 micelles of baicalein could interfere with mitochondria to overcome MRP2-mediated efflux and offer improved anti-parkinsonian activity. Mol Pharmaceutics. 14(10):3331–3342.
   PubMed Web of Science ®Google Scholar
• Choudhry H, Harris AL. 2018. Advances in hypoxia-inducible factor biology. Cell Metab. 27(2):281–298.
   PubMed Web of Science ®Google Scholar
• Dazert P, Suofu Y, Grube M, Popa-Wagner A, Kroemer HK, Jedlitschky G, Kessler C. 2006. Differential regulation of transport proteins in the periinfarct region following reversible middle cerebral artery occlusion in rats. Neuroscience. 142(4):1071–1079.
   PubMed Web of Science ®Google Scholar
• de Castro FA, Simões BP, Coelho EB, Lanchote VL. 2017. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis. J Clin Pharmacol. 57(6):784–795.
   PubMed Web of Science ®Google Scholar
• Dou Z, Rong X, Zhao E, Zhang L, Lv Y. 2019. Neuroprotection of resveratrol against focal cerebral ischemia/reperfusion injury in mice through a mechanism targeting gut-brain axis. Cell Mol Neurobiol. 39(6):883–898.
   PubMed Web of Science ®Google Scholar
• Du Souich P, Varin F, Courteau H. 1986. Effect of hypercapnia and/or hypoxemia and metabolic acidosis on kinetics and concentrations of phenytoin in the cerebrospinal fluid of conscious rabbits. Neuropharmacology. 25(8):857–862.
   PubMed Web of Science ®Google Scholar
• Duan Y, Bai X, Yang J, Zhou Y, Gu W, Liu G, Wang Q, Zhu J, La L, Li X. 2022. Exposure to high-altitude environment is associated with drug transporters change: microRNA-873-5p-mediated alteration of function and expression levels of drug transporters under hypoxia. Drug Metab Dispos. 50(2):174–186.
   PubMed Web of Science ®Google Scholar
• Ek CJ, D'Angelo B, Baburamani AA, Lehner C, Leverin AL, Smith PL, Nilsson H, Svedin P, Hagberg H, Mallard C. 2015. Brain barrier properties and cerebral blood flow in neonatal mice exposed to cerebral hypoxia-ischemia. J Cereb Blood Flow Metab. 35(5):818–827.
   PubMed Web of Science ®Google Scholar
• Engelhardt S, Al-Ahmad AJ, Gassmann M, Ogunshola OO. 2014. Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes through a hypoxia-inducible factor-1 (HIF-1) dependent mechanism. J Cell Physiol. 229(8):1096–1105.
   PubMed Web of Science ®Google Scholar
• Eser Ocak P, Ocak U, Sherchan P, Zhang JH, Tang J. 2020. Insights into major facilitator superfamily domain-containing protein-2a (Mfsd2a) in physiology and pathophysiology. What do we know so far? J Neurosci Res. 98(1):29–41.
   PubMed Web of Science ®Google Scholar
• Fischer S, Renz D, Kleinstück J, Schaper W, Karliczek GF. 2004. In vitro effects of anaesthetic agents on the blood–brain barrier. Anaesthesist. 53(12):1177–1184.
   PubMed Web of Science ®Google Scholar
• Gong W, Liu S, Xu P, Fan M, Xue M. 2015. Simultaneous quantification of diazepam and dexamethasone in plasma by high-performance liquid chromatography with tandem mass spectrometry and its application to a pharmacokinetic comparison between normoxic and hypoxic rats. Molecules. 20(4):6901–6912.
   PubMed Web of Science ®Google Scholar
• Haduch A, Daniel WA. 2018. The engagement of brain cytochrome P450 in the metabolism of endogenous neuroactive substrates: a possible role in mental disorders. Drug Metab Rev. 50(4):415–429.
   PubMed Web of Science ®Google Scholar
• Han L, Jiang C. 2021. Evolution of blood–brain barrier in brain diseases and related systemic nanoscale brain targeting drug delivery strategies. Acta Pharm Sin B. 11(8):2306–2325.
   PubMed Web of Science ®Google Scholar
• Han L, Qu Q, Aydin D, Panova O, Robertson MJ, Xu Y, Dror RO, Skiniotis G, Feng L. 2022. Structure and mechanism of the SGLT family of glucose transporters. Nature. 601(7892):274–279.
   PubMed Web of Science ®Google Scholar
• Han M, Wang S, Yang N, Wang X, Zhao W, Saed HS, Daubon T, Huang B, Chen A, Li G, et al. 2020. Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma. EMBO Mol Med. 12(1):e10924.
   PubMed Web of Science ®Google Scholar
• Hyun SW, Jung YS. 2014. Hypoxia induces FoxO3a-mediated dysfunction of blood–brain barrier. Biochem Biophys Res Commun. 450(4):1638–1642.
   PubMed Web of Science ®Google Scholar
• Ihezie SA, Mathew IE, McBride DW, Dienel A, Blackburn SL, Thankamani Pandit PK. 2021. Epigenetics in blood–brain barrier disruption. Fluids Barriers CNS. 18(1):17.
   PubMed Web of Science ®Google Scholar
• Jacob A, Potin S, Bruno S, Dominique C, Jean-Michel S, Emmanuel C, Carole P, Xavier D. 2015. Hypoxia interferes with aryl hydrocarbon receptor pathway in hCMEC/D3 human cerebral microvascular endothelial cells. J Neurochem. 132(4):373–383.
   PubMed Web of Science ®Google Scholar
• Kadry H, Noorani B, Cucullo L. 2020. A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 17(1):69.
   PubMed Web of Science ®Google Scholar
• Kagawa Y, Yamamoto Y, Ueno A, Maeda T, Obi T. 2021. Impact of CYP2D6, CYP3A5, and ABCB1 polymorphisms on plasma concentrations of donepezil and its metabolite in patients with Alzheimer Disease. Ther Drug Monit. 43(3):429–435.
   PubMed Web of Science ®Google Scholar
• Kalliokoski A, Niemi M. 2009. Impact of OATP transporters on pharmacokinetics. Br J Pharmacol. 158(3):693–705.
   PubMed Web of Science ®Google Scholar
• Kilic E, Spudich A, Kilic U, Rentsch KM, Vig R, Matter CM, Wunderli-Allenspach H, Fritschy JM, Bassetti CL, Hermann DM. 2008. ABCC1: a gateway for pharmacological compounds to the ischaemic brain. Brain. 131(10):2679–2689.
   PubMed Web of Science ®Google Scholar
• Kodama S, Koike C, Negishi M, Yamamoto Y. 2004. Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol Cell Biol. 24(18):7931–7940.
   PubMed Web of Science ®Google Scholar
• Kooij G, Mizee MR, van Horssen J, Reijerkerk A, Witte ME, Drexhage JA, van der Pol SM, van Het Hof B, Scheffer G, Scheper R, et al. 2011. Adenosine triphosphate-binding cassette transporters mediate chemokine (C–C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis. Brain. 134(2):555–570.
   PubMed Web of Science ®Google Scholar
• Kortekaas R, Leenders KL, van Oostrom JCH, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH. 2005. Blood–brain barrier dysfunction in Parkinsonian midbrain in vivo. Ann Neurol. 57(2):176–179.
   PubMed Web of Science ®Google Scholar
• Krohn M, Lange C, Hofrichter J, Scheffler K, Stenzel J, Steffen J, Schumacher T, Brüning T, Plath AS, Alfen F, et al. 2011. Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice. J Clin Invest. 121(10):3924–3931.
   PubMed Web of Science ®Google Scholar
• Kuban W, Daniel WA. 2021. Cytochrome P450 expression and regulation in the brain. Drug Metab Rev. 53(1):1–29.
   PubMed Web of Science ®Google Scholar
• Li H, Sun J, Du J, Wang F, Fang R, Yu C, Xiong J, Chen W, Lu Z, Liu J. 2018. Clostridium butyricum exerts a neuroprotective effect in a mouse model of traumatic brain injury via the gut-brain axis. Neurogastroenterol Motil. 30(5):e13260.
   PubMed Web of Science ®Google Scholar
• Li W, Jia Z, Xie H, Zhang J, Wang Y, Hao Y, Wang R. 2013.Effect of acute exposure to high altitude on the pharmacokinetics of propranolol. J. Cent. South Univ. 38(9):909–914. Chinese.
   Google Scholar
• Li W, Wang R, Xie H, Zhang J, Wang Y, Jia Z. 2015. Effects on pharmacokinetics of propranolol and other factors in rats after acute exposure to high altitude at 4,010 m. Cell Biochem Biophys. 72(1):27–36.
   PubMed Web of Science ®Google Scholar
• Li X, Wang X, Li Y, Yuan M, Zhu J, Su X, Yao X, Fan X, Duan Y. 2014a. Effect of exposure to acute and chronic high-altitude hypoxia on the activity and expression of CYP1A2, CYP2D6, CYP2C9, CYP2C19 and NAT2 in rats. Pharmacology. 93(1-2):76–83.
   PubMed Web of Science ®Google Scholar
• Li X, Wang X, Li Y, Zhu J, Su X, Yao X, Fan X, Duan Y. 2014b. The activity, protein, and mRNA expression of CYP2E1 and CYP3A1 in rats after exposure to acute and chronic high altitude hypoxia. High Alt Med Bio. 15(4):491–496.
   PubMed Web of Science ®Google Scholar
• Lidin E, Sköld MK, Angéria M, Davidsson J, Risling M. 2022. Hippocampal expression of cytochrome P450 1B1 in penetrating traumatic brain injury. IJMS. 23(2):722.
   Web of Science ®Google Scholar
• Lin YT, Wu KJ. 2020. Epigenetic regulation of epithelial-mesenchymal transition: focusing on hypoxia and TGF-β signaling. J Biomed Sci. 27(1):39.
   PubMed Web of Science ®Google Scholar
• Liu G, Bai X, Duan Y, Zhu J, Yang J, Wang Q, Zhou Y, Gu W. 2021. [Changes in the intestinal flora of rats under high altitude hypoxia]. Acta Pharm Sin. 56(4):1100–1108. Chinese.
   Google Scholar
• Liu J, Wang W, Wang L, Chen S, Tian B, Huang K, Corrigan CJ, Ying S, Wang W, Wang C. 2018. IL-33 Initiates vascular remodelling in hypoxic pulmonary hypertension by up-regulating HIF-1α and VEGF expression in vascular endothelial cells. EBioMedicine. 33:196–210.
   PubMed Web of Science ®Google Scholar
• Liu JS, He YJ, Zhang J, Li J, Yu X, Cao Z, Meng F, Zhao Y, Wu X, Shen T, et al. 2015. Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery. Biomaterials. 74:64–76.
   PubMed Web of Science ®Google Scholar
• Liu M, Alkayed NJ. 2005. Hypoxic preconditioning and tolerance via hypoxia inducible factor (HIF) 1alpha-linked induction of P450 2C11 epoxygenase in astrocytes. J Cereb Blood Flow Metab. 25(8):939–948.
   PubMed Web of Science ®Google Scholar
• Lu DY, Yu WH, Yeh WL, Tang CH, Leung YM, Wong KL, Chen YF, Lai CH, Fu WM. 2009. Hypoxia-induced matrix metalloproteinase-13 expression in astrocytes enhances permeability of brain endothelial cells. J Cell Physiol. 220(1):163–173.
   PubMed Web of Science ®Google Scholar
• Lu F, Zhu J, Guo S, Wong BJ, Chehab FF, Ferriero DM, Jiang X. 2018. Upregulation of cholesterol 24-hydroxylase following hypoxia-ischemia in neonatal mouse brain. Pediatr Res. 83(6):1218–1227.
   PubMed Web of Science ®Google Scholar
• Ma F, Zhang X, Yin KJ. 2020. MicroRNAs in central nervous system diseases: a prospective role in regulating blood–brain barrier integrity. Exp Neurol. 323:113094.
   PubMed Web of Science ®Google Scholar
• Ma J, Wang J, Cheng J, Xiao W, Fan K, Gu J, Yu B, Yin G, Wu J, Ren J, et al. 2017. Impacts of blast-induced traumatic brain injury on expressions of hepatic cytochrome P450 1A2, 2B1, 2D1, and 3A2 in rats. Cell Mol Neurobiol. 37(1):111–120.
   PubMed Web of Science ®Google Scholar
• Makuch-Kocka A, Andres-Mach M, Zagaja M, Śmiech A, Pizoń M, Flieger J, Cielecka-Piontek J, Plech T. 2021. Effect of chronic administration of 5- (3-chlorophenyl) - 4- Hexyl - 2, 4 - Dihydro - 3H - 1, 2, 4 - Triazole - 3 - Thione (TP - 315) -a new anticonvulsant drug candidate on living organisms. IJMS. 22(7):3358.
   Web of Science ®Google Scholar
• Martinez-Hernandez A, Perez-Guerrero EE, Macias-Islas MA, Nava-Valdivia CA, Villagomez-Vega A, Contreras-Haro B, Garcia-Ortega YE, Esparza-Guerrero Y, Gallardo-Moya SG, Gamez-Nava JI, et al. 2021. Polymorphisms CYP2R1 rs10766197 and CYP27B1 rs10877012 in multiple sclerosis: a case-control study. J Immunol Res. 2021:1–11.
   Web of Science ®Google Scholar
• Miller DS. 2015. Regulation of ABC transporters at the blood–brain barrier. Clin Pharmacol Ther. 97(4):395–403.
   PubMed Web of Science ®Google Scholar
• Mizutani T, Hattori A. 2005. New horizon of MDR1 (P-glycoprotein) study. Drug Metab Rev. 37(3):489–510.
   PubMed Web of Science ®Google Scholar
• Mojsilovic-Petrovic J, Callaghan D, Cui H, Dean C, Stanimirovic DB, Zhang W. 2007. Hypoxia-inducible factor-1 (HIF-1) is involved in the regulation of hypoxia-stimulated expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) and MCP-5 (Ccl12) in astrocytes. J Neuroinflammation. 4(1):12.
   PubMed Web of Science ®Google Scholar
• Neuhaus W, Gaiser F, Mahringer A, Franz J, Riethmüller C, Förster C. 2014. The pivotal role of astrocytes in an in vitro stroke model of the blood–brain barrier. Front Cell Neurosci. 8:352.
   PubMed Web of Science ®Google Scholar
• Nian Y, Xin Y, Yang J, Zhu L, Liu G, Li XY. 2019. [Effect of simulated high altitude hypoxia on pharmacokinetics of acetaminophen]. West China J Pharm Sci. 34(2):141–146. Chinese.
   Google Scholar
• Nomura M, Yamagishi S, Harada S, Hayashi Y, Yamashima T, Yamashita J, Yamamoto H. 1995. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J Biol Chem. 270(47):28316–28324.
   PubMed Web of Science ®Google Scholar
• Obaidat A, Roth M, Hagenbuch B. 2012. The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. Annu Rev Pharmacol Toxicol. 52(1):135–151.
   PubMed Web of Science ®Google Scholar
• Ozgür B, Helms HCC, Tornabene E, Brodin B. 2022. Hypoxia increases expression of selected blood–brain barrier transporters GLUT-1, P-gp, SLC7A5 and TFRC, while maintaining barrier integrity, in brain capillary endothelial monolayers. Fluids Barriers CNS. 19(1):1–17.
   PubMed Web of Science ®Google Scholar
• Park TE, Mustafaoglu N, Herland A, Hasselkus R, Mannix R, FitzGerald EA, Prantil-Baun R, Watters A, Henry O, Benz M, et al. 2019. Hypoxia-enhanced blood–brain barrier chip recapitulates human barrier function and shuttling of drugs and antibodies. Nat Commun. 10(1):2621.
   PubMed Web of Science ®Google Scholar
• Parker A, Fonseca S, Carding SR. 2020. Gut microbes and metabolites as modulators of blood–brain barrier integrity and brain health. Gut Microbes. 11(2):135–157.
   PubMed Web of Science ®Google Scholar
• Pottoo FH, Sharma S, Javed MN, Barkat MA, Alam MS, Naim MJ, Alam O, Ansari MA, Barreto GE, Ashraf GM, et al. 2020. Lipid-based nanoformulations in the treatment of neurological disorders. Drug Metab Rev. 52(1):185–204.
   PubMed Web of Science ®Google Scholar
• Rattner A, Williams J, Nathans J. 2019. Roles of HIFs and VEGF in angiogenesis in the retina and brain. J Clin Invest. 129(9):3807–3820.
   PubMed Web of Science ®Google Scholar
• Ribatti D, Nico B, Crivellato E. 2011. The role of pericytes in angiogenesis. Int J Dev Biol. 55(3):261–268.
   PubMed Web of Science ®Google Scholar
• Ritschel WA, Paulos C, Arancibia A, Pezzani M, Agrawal MA, Wetzelsberger KM, Lücker PW. 1996. Pharmacokinetics of meperidine in healthy volunteers after short and long-term exposure to high altitude. J Clin Pharmacol. 36(7):610–616.
   PubMed Web of Science ®Google Scholar
• Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM. 2018. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer. 18(7):452–464.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Grande B, Ichkova A, Lemarchant S, Badaut J. 2017. Early to long-term alterations of CNS barriers after traumatic brain injury: considerations for drug development. Aaps J. 19(6):1615–1625.
   PubMed Web of Science ®Google Scholar
• Ronaldson PT, Davis TP. 2020. Regulation of blood–brain barrier integrity by microglia in health and disease: a therapeutic opportunity. J Cereb Blood Flow Metab. 40(1_suppl):S6–S24.
   PubMed Web of Science ®Google Scholar
• Sakakibara Y, Katoh M, Imai K, Kondo Y, Asai Y, Ikushiro S, Nadai M. 2016. Expression of UGT1A subfamily in rat brain. Biopharm Drug Dispos. 37(5):314–319.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ, Hardy J. 2016. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med. 8(6):595–608.
   PubMed Web of Science ®Google Scholar
• Shang J, Yamashita T, Tian F, Li X, Liu X, Shi X, Nakano Y, Tsunoda K, Nomura E, Sasaki R, et al. 2019. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer’s disease model mouse. Brain Res. 1723:146379.
   PubMed Web of Science ®Google Scholar
• Singh AK, Kashyap MP, Jahan S, Kumar V, Tripathi VK, Siddiqui MA, Yadav S, Khanna VK, Das V, Jain SK, et al. 2012. Expression and inducibility of cytochrome P450s (CYP1A1, 2B6, 2E1, 3A4) in human cord blood CD34(+) stem cell-derived differentiating neuronal cells. Toxicol Sci. 129(2):392–410.
   PubMed Web of Science ®Google Scholar
• Stamatovic SM, Keep RF, Kunkel SL, Andjelkovic AV. 2003. Potential role of MCP-1 in endothelial cell tight junction opening: signaling via Rho and Rho kinase. J Cell Sci. 116(Pt 22):4615–4628.
   PubMed Web of Science ®Google Scholar
• Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, et al. 2003. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-toler-ance states. Lancet. 362(9389):1028–1037.
   PubMed Web of Science ®Google Scholar
• Storelli F, Billington S, Kumar AR, Unadkat JD. 2021. Abundance of P-Glycoprotein and other drug transporters at the human blood–brain barrier in Alzheimer’s disease: a quantitative targeted proteomic study. Clin Pharmacol Ther. 109(3):667–675.
   PubMed Web of Science ®Google Scholar
• Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. 2019. Blood–brain barrier: from physiology to disease and back. Physiol Rev. 99(1):21–78.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Nangaku M. 2013. Angiogenesis and hypoxia in the kidney. Nat Rev Nephrol. 9(4):211–222.
   PubMed Web of Science ®Google Scholar
• Thompson BJ, Sanchez-Covarrubias L, Slosky LM, Zhang Y, Laracuente ML, Ronaldson PT. 2014. Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood–brain barrier: relevance to CNS drug delivery. J Cereb Blood Flow Metab. 34(4):699–707.
   PubMed Web of Science ®Google Scholar
• Tiwary S, Morales JE, Kwiatkowski SC, Lang FF, Rao G, McCarty JH. 2018. Metastatic brain tumors disrupt the blood–brain barrier and alter lipid metabolism by inhibiting expression of the endothelial cell fatty acid transporter mfsd2a. Sci Rep. 8(1):8267.
   PubMed Web of Science ®Google Scholar
• Tjakra M, Wang Y, Vania V, Hou Z, Durkan C, Wang N, Wang G. 2020. Overview of crosstalk between multiple factor of transcytosis in blood–brain barrier. Front Neurosci. 13:1436.
   PubMed Web of Science ®Google Scholar
• Ur Rasheed MS, Mishra AK, Singh MP. 2017. Cytochrome P450 2D6 and Parkinson’s disease: polymorphism, metabolic role, risk and rrotection. Neurochem Res. 42(12):3353–3361.
   PubMed Web of Science ®Google Scholar
• van Vliet EA, Redeker S, Aronica E, Edelbroek PM, Gorter JA. 2005. Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats. Epilepsia. 46(10):1569–1580.
   PubMed Web of Science ®Google Scholar
• Veys K, Fan Z, Ghobrial M, Bouché A, García-Caballero M, Vriens K, Conchinha NV, Seuwen A, Schlegel F, Gorski T, et al. 2020. Role of the GLUT1 glucose transporter in postnatal CNS angiogenesis and blood–brain barrier integrity. Circ Res. 127(4):466–482.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zuo Z. 2018. Impact of transporters and enzymes from blood-cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake. Expert Opin Drug Metab Toxicol. 14(9):961–972.
   PubMed Web of Science ®Google Scholar
• Wang X, Suofu Y, Akpinar B, Baranov SV, Kim J, Carlisle DL, Zhang Y, Friedlander RM. 2017. Systemic antimiR-337-3p delivery inhibits cerebral ischemia-mediated injury. Neurobiol Dis. 105:156–163.
   PubMed Web of Science ®Google Scholar
• Wang Y, Meng X, Wang A, Xie X, Pan Y, Johnston SC, Li H, Bath PM, Dong Q, Xu A, et al. 2021. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA. N Engl J Med. 385(27):2520–2530.
   PubMed Web of Science ®Google Scholar
• Welcome MO. 2019. Gut microbiota disorder, gut epithelial and blood–brain barrier dysfunctions in etiopathogenesis of dementia: molecular mechanisms and signaling pathways. Neuromol Med. 21(3):205–226.
   PubMed Web of Science ®Google Scholar
• Wijesuriya HC, Bullock JY, Faull RL, Hladky SB, Barrand MA. 2010. ABC efflux transporters in brain vasculature of Alzheimer’s subjects. Brain Res. 1358:228–238.
   PubMed Web of Science ®Google Scholar
• Witt KA, Mark KS, Hom S, Davis TP. 2003. Effects of hypoxia-reoxygenation on rat blood–brain barrier permeability and tight junctional protein expression. Am J Physiol Heart Circ Physiol. 285(6):H2820–H2831.
   PubMed Web of Science ®Google Scholar
• Witt KA, Mark KS, Sandoval KE, Davis TP. 2008. Reoxygenation stress on blood–brain barrier paracellular permeability and edema in the rat. Microvasc Res. 75(1):91–96.
   PubMed Web of Science ®Google Scholar
• Xiong H, Callaghan D, Jones A, Bai J, Rasquinha I, Smith C, Pei K, Walker D, Lue LF, Stanimirovic D, et al. 2009. ABCG2 is upregulated in Alzheimer’s brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood–brain barrier for Aβ(1-40) peptides. J Neurosci. 29(17):5463–5475.
   PubMed Web of Science ®Google Scholar
• Xiong M, Chen LX, Ma SM, Yang Y, Zhou WH. 2013. Short-term effects of hypothermia on axonal injury, preoligodendrocyte accumulation and oligodendrocyte myelination after hypoxia-ischemia in the hippocampus of immature rat brain. Dev Neurosci. 35(1):17–27.
   PubMed Web of Science ®Google Scholar
• Xu D, Huang S, Wang H, Xie W. 2018. Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors. Drug Metab Rev. 50(4):407–414.
   PubMed Web of Science ®Google Scholar
• Xu L, Li G, Tang X, Feng C, Li M, Jiang X, Gu Y, Yun Y, Lu L, Feng X, et al. 2021. MiR-375-3p mediates reduced pineal function in hypoxia-ischemia brain damage. Exp Neurol. 344:113814.
   PubMed Web of Science ®Google Scholar
• Yeh WL, Lu DY, Lin CJ, Liou HC, Fu WM. 2007. Inhibition of hypoxia-induced increase of blood–brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol Pharmacol. 72(2):440–449.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li X, Qiao S, Yang D, Li Z, Xu J, Li W, Su L, Liu W. 2021. Occludin degradation makes brain microvascular endothelial cells more vulnerable to reperfusion injury in vitro. J Neurochem. 156(3):352–366.
   PubMed Web of Science ®Google Scholar
• Ziegler N, Awwad K, Fisslthaler B, Reis M, Devraj K, Corada M, Minardi SP, Dejana E, Plate KH, Fleming I, et al. 2016. β-Catenin is required for endothelial Cyp1b1 regulation influencing metabolic barrier function. J Neurosci. 36(34):8921–8935.
   PubMed Web of Science ®Google Scholar
• Zolotoff C, Voirin AC, Puech C, Roche F, Perek N. 2020. Intermittent hypoxia and its impact on Nrf2/HIF-1α expression and ABC transporters: an in vitro human blood–brain barrier model study. Cell Physiol Biochem. 54(6):1231–1248.
   PubMedGoogle Scholar
• Zordoky BN, El-Kadi AO. 2009. Role of NF-kappa B in the regulation of cytochrome P450 enzymes. CDM. 10(2):164–178.
   Web of Science ®Google Scholar